Leerink Partnrs Brokers Boost Earnings Estimates for TNGX
Tango Therapeutics, Inc. (NASDAQ:TNGX – Free Report) – Analysts at Leerink Partnrs boosted their Q2 2025 earnings per share (EPS) estimates for Tango Therapeutics in a note issued to investors on Monday, May 12th. Leerink Partnrs analyst A. Berens now expects that the company will post earnings per share of ($0.29) for the quarter, up […]
Tango Therapeutics, Inc. (NASDAQ:TNGX – Free Report) – Analysts at Leerink Partnrs boosted their Q2 2025 earnings per share (EPS) estimates for Tango Therapeutics in a note issued to investors on Monday, May 12th. Leerink Partnrs analyst A. Berens now expects that the company will post earnings per share of ($0.29) for the quarter, up […]
